-
-
New dosing option approved for Viracept; Labeling rule proposed for dietary supplements; FDA completes first phase of Drugs@FDA
-
Several recent studies add to the evidence that HIV infection and possibly highly active antiretroviral treatment (HAART) increase risks or at least are associated with the loss of bone mass among women and children.
-
A San Francisco study of a telephone hotline for people who may have been exposed to HIV through nonoccupational risk behavior shows that there is a reasonable demand for post-exposure prophylaxis (PEP).
-
Here are assumptions the Washington, DC-based ADAP Working Group used to make its funding projects for the coming year:
-
Physicians often have to give bad and distressing news to patients. The screening tests have found cancer. An ultrasound shows that a pregnancy is not progressing normally. A planned treatment regimen is not having the desired result.
-
In July 2002, the North Carolina Medical Board made history by becoming the first state board to revoke the license of a physician for giving what it considered to be false and misleading testimony in a medical malpractice case.
-
The department of maternal and fetal medicine at Vanderbilt University Medical Center (VUMC) in Nashville, TN, sees many patients referred in from rural parts of the state to receive specialized care not available in their own communities.
-
-
Confusion in research circles over privacy requirements under HIPAA is seen in a flap at the Johns Hopkins Medical School, which sent a letter to the Department of Health and Human Services asking whether it could request patients permission to use their medical records for research.